1University of Bologna Bologna, Italy [email protected]
2University of California at San Diego San Diego, CA
3University of Paris Sud Paris, France
Dr. Galiè reports receiving lecture fees from Actelion, Bayer, GlaxoSmithKline, Eli Lilly, and Pfizer and serving on steering committees for Actelion, Bayer, GlaxoSmithKline, Eli Lilly, Pfizer, and United Therapeutics; his institution has received research grants from Actelion, GlaxoSmithKline, Eli Lilly, and Pfizer. Dr. Rubin reports serving as an investigator and consultant for Pfizer, Gilead, Actelion, and United Therapeutics and having an equity interest in United Therapeutics. Dr. Simonneau reports receiving consulting and lecture fees from Actelion, Bayer, GlaxoSmithKline, Eli Lilly, and Pfizer and research grants from Actelion, GlaxoSmithKline, Eli Lilly, Pfizer, and United Therapeutics. No other potential conflict of interest relevant to this letter was reported.
